AMR, One Health and the environmentdoi:10.1038/s41564-023-01351-9Larsson D. G. J.Gaze W. H.Laxminarayan R.Topp E.Nature Publishing Group UKNature Microbiology
题目:Environmental Dimension of AMR under the One Health Agenda 时间:2021年11月19日(星期五)北京时间16:00 主办方:United Nations Environment Programme (UNEP) 、Institute of Urban Environment, Chinese Academy of Sciences (IUE, CAS) 、Alliance of International Science Organizations (ANSO)、Center for...
ONE HEALTH 抗微生物药物耐药性对人类、动物、植物和环境构成威胁,影响我们所有人。为了有效降低抗微生物药物耐药性,所有部门必须谨慎和适当地使用抗微生物药物,采取预防措施以降低感染的发生率,并遵循处理受抗微生物药物污染废物的良好...
(AMR) is one of the most alarming and emerging threats to human and animal health of this age led majorly by the misuse of antimicrobials (AMs), which creates the necessity of understanding the practitioner's depth of knowledge, meeting essential standards, adherence of guidelines and prescribing...
statistical, and epidemiological approaches to 1) study the composition, function, and dynamics of human and animal microbiomes in health and diseases, and 2) to monitor antimicrobial resistance (AMR) and the resistome in humans, animals, and the environment using a holistic One Health approach. ...
“微生物药物耐药性(AMR)的起因与影响在于人类、陆地和水生动物、植物、食物、饲料和环境等多个方面,其涉及广泛的利益攸关方且互相关联。因此,没有任何一个政府部门或独立组织能够单独解决这个问题,必须通过“同一健康”的方针从多个方面解决AMR这一问题,以及采取“多
Agriculture Aircraft Artificial Intelligence Automation Autonomous vehicles Business Computing Construction Culture Design Drones Economy Energy Engineering Environment Health Humanoids Industrial robots Industry Infrastructure Investments Logistics Manufacturing Marine Material handling Materials Mining Promoted Research Robot...
Tropical Medicine and Infectious Disease Commentary Antimicrobial Resistance (AMR) in the Food Chain: Trade, One Health and Codex Anna George 1,2 1 Centre on Global Health Security, Chatham House, London SW1Y 4LE, UK; anna.george.c@gmail.com or Anna.George@murdoch.edu.au 2 Public Policy ...
Healthcare-associated infections (HAIs) affect up to 15% of all hospitalized patients, representing a global concern. Major causes include the persistent microbial contamination of hospital environment, and the growing antimicrobial-resistance (AMR) of HAI-associated microbes. The hospital environment repr...
However, in the face of unique scientific and financial hurdles, the number of potential drugs in the pipeline has dwindled. Despite these difficulties, some companies, including GSK, are pressing ahead, hoping to revive the field and take on one of the biggest health challenges facing hu...